Advertisement

Hyperuricemia and risk of stroke: A systematic review and meta-analysis of prospective studies

      Abstract

      Introduction

      Hyperuricemia may be associated with an increased risk of stroke, but to date results from prospective studies have been inconsistent. This study aimed to evaluate the association between hyperuricemia and risk of stroke incidence and mortality by performing a meta-analysis.

      Materials and methods

      Studies were identified by searching multiple electronic databases through July 13, 2013, and by reviewing reference lists of obtained articles. Prospective studies reported a multivariate-adjusted estimate, represented as relative risk (RRs) with 95% confidence intervals (CIs) for the association between hyperuricemia and risk of stroke incidence and mortality were eligible. A random-effects model was used to compute the pooled risk estimate.

      Results

      A total of fourteen articles including results from 15 prospective studies with 22,571 cases of stroke and 1,042,358 participants were included in the meta-analysis. Overall, presence of hyperuricemia was associated with a significantly greater risk of both stroke incidence (RR, 1.22; 95% CI, 1.02–1.46) and mortality (RR, 1.33; 95% CI, 1.24–1.43). In addition, the pooled estimate of multivariate RRs of stroke incidence and mortality were 1.08 (95% CI: 0.85–1.38); 1.26 (95% CI: 1.14–1.40) among men and 1.25 (95% CI: 1.04–1.46); 1.41 (95% CI: 1.31–1.52) among women respectively.

      Conclusions

      Results from this meta-analysis indicate that hyperuricemia may modestly increase the risks of both stroke incidence and mortality. Future studies should explore whether hyperuricemia is a modifiable risk factor for stroke.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Donnan G.A.
        • Fisher M.
        • Macleod M.
        • Davis S.M.
        Stroke.
        Lancet. 2008; 371: 1612-1623
        • WHO
        The global burden of disease: 2004 update.
        WHO, Geneva, Switzerland2008
        • WHO
        World Health Organisation: the 10 leading causes of death by broad income group.
        2008 (World health organisation website:) ([accessed August 2012])
        • Strong K.
        • Mathers C.
        • Bonita R.
        Preventing stroke: saving lives around the world.
        Lancet Neurol. 2007; 6: 182-187
        • Roger V.L.
        • Go A.S.
        • Lloyd-Jones D.M.
        • et al.
        Heart disease and stroke statistics–2012 update: a report from the American Heart Association.
        Circulation. 2012; 125: e2-e220
        • Sidney S.
        • Rosamond W.D.
        • Howard V.J.
        • Luepker R.V.
        The “heart disease and stroke statistics–2013 update” and the need for a national cardiovascular surveillance system.
        Circulation. 2013; 127: 21-23
        • Becker B.F.
        Towards the physiological function of uric acid.
        Free Radic Biol Med. 1993; 14: 615-631
        • Sinha S.
        • Singh S.N.
        • Ray U.S.
        Total antioxidant status at high altitude in lowlanders and native highlanders: role of uric acid.
        High Alt Med Biol. 2009; 10: 269-274
        • Becker M.A.
        • Schumacher Jr., H.R.
        • Wortmann R.L.
        • et al.
        Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
        N Engl J Med. 2005; 353: 2450-2461
        • Yu Z.F.
        • Bruce-Keller A.J.
        • Goodman Y.
        • Mattson M.P.
        Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo.
        J Neurosci Res. 1998; 53: 613-625
        • Chamorro A.
        • Obach V.
        • Cervera A.
        • Revilla M.
        • Deulofeu R.
        • Aponte J.H.
        Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke.
        Stroke. 2002; 33: 1048-1052
        • Johnson R.J.
        • Kang D.H.
        • Feig D.
        • et al.
        Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease.
        Hypertension. 2003; 41: 1183-1190
        • Nakanishi N.
        • Okamoto M.
        • Yoshida H.
        • Matsuo Y.
        • Suzuki K.
        • Tatara K.
        Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers.
        Eur J Epidemiol. 2003; 18: 523-530
        • Feig D.I.
        • Kang D.H.
        • Johnson R.J.
        Uric acid and cardiovascular risk.
        N Engl J Med. 2008; 359: 1811-1821
        • Lehto S.
        • Niskanen L.
        • Ronnemaa T.
        • Laakso M.
        Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus.
        Stroke. 1998; 29: 635-639
        • Chien K.L.
        • Hsu H.C.
        • Sung F.C.
        • Su T.C.
        • Chen M.F.
        • Lee Y.T.
        Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan Community Cardiovascular Cohort Study.
        Atherosclerosis. 2005; 183: 147-155
        • Bos M.J.
        • Koudstaal P.J.
        • Hofman A.
        • Witteman J.C.
        • Breteler M.M.
        Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study.
        Stroke. 2006; 37: 1503-1507
        • Hozawa A.
        • Folsom A.R.
        • Ibrahim H.
        • Nieto F.J.
        • Rosamond W.D.
        • Shahar E.
        Serum uric acid and risk of ischemic stroke: the ARIC Study.
        Atherosclerosis. 2006; 187: 401-407
        • Koton S.
        • Howard S.C.
        • Warlow C.P.
        • Murphy M.F.
        • Rothwell P.M.
        Serum urate predicts long-term risk of acute coronary events in women after a transient ischaemic attack and stroke.
        Cerebrovasc Dis. 2008; 26: 517-524
        • Sakata K.
        • Hashimoto T.
        • Ueshima H.
        • Okayama A.
        Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980–1994. National integrated projects for prospective observation of non-communicable diseases and its trend in the aged.
        Eur J Epidemiol. 2001; 17: 461-468
        • Mazza A.
        • Pessina A.C.
        • Pavei A.
        • Scarpa R.
        • Tikhonoff V.
        • Casiglia E.
        Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly.
        Eur J Epidemiol. 2001; 17: 1097-1104
        • Jee S.H.
        • Lee S.Y.
        • Kim M.T.
        Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men.
        Eur J Cardiovasc Prev Rehabil. 2004; 11: 185-191
        • Gerber Y.
        • Tanne D.
        • Medalie J.H.
        • Goldbourt U.
        Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes.
        Eur J Cardiovasc Prev Rehabil. 2006; 13: 193-198
        • Strasak A.
        • Ruttmann E.
        • Brant L.
        • et al.
        Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men.
        Clin Chem. 2008; 54: 273-284
        • Strasak A.M.
        • Kelleher C.C.
        • Brant L.J.
        • et al.
        Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study.
        Int J Cardiol. 2008; 125: 232-239
        • Chen J.H.
        • Chuang S.Y.
        • Chen H.J.
        • Yeh W.T.
        • Pan W.H.
        Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.
        Arthritis Rheum. 2009; 61: 225-232
        • Holme I.
        • Aastveit A.H.
        • Hammar N.
        • Jungner I.
        • Walldius G.
        Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).
        J Intern Med. 2009; 266: 558-570
        • Kuo C.F.
        • See L.C.
        • Yu K.H.
        • Chou I.J.
        • Chiou M.J.
        • Luo S.F.
        Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality.
        Rheumatology (Oxford). 2013; 52: 127-134
        • Kanellis J.
        • Johnson R.J.
        Editorial comment – elevated uric acid and ischemic stroke: accumulating evidence that it is injurious and not neuroprotective.
        Stroke. 2003; 34: 1956-1957
        • Weir C.J.
        • Muir S.W.
        • Walters M.R.
        • Lees K.R.
        Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke.
        Stroke. 2003; 34: 1951-1956
        • Kim S.Y.
        • Guevara J.P.
        • Kim K.M.
        • Choi H.K.
        • Heitjan D.F.
        • Albert D.A.
        Hyperuricemia and risk of stroke: a systematic review and meta-analysis.
        Arthritis Rheum. 2009; 61: 885-892
        • Wells G.A.
        • Shea B.
        • O'Connell D.
        • Petersen J.
        • Welch V.
        The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses.
        (Available:) ([accessed 31.03.12])
        • DerSimonian R.
        • Laird N.
        Meta-analysis in clinical trials.
        Control Clin Trials. 1986; 7: 177-188
        • Higgins J.P.
        • Thompson S.G.
        • Deeks J.J.
        • Altman D.G.
        Measuring inconsistency in meta-analyses.
        BMJ. 2003; 327: 557-560
        • Higgins J.P.T.
        • Green S.
        Cochrane handbook for systematic reviews of interventions.
        The Cochrane Collaboration, Oxford, UK2008
        • Begg C.B.
        • Mazumdar M.
        Operating characteristics of a rank correlation test for publication bias.
        Biometrics. 1994; 50: 1088-1101
        • Dichgans M.
        Genetics of ischaemic stroke.
        Lancet Neurol. 2007; 6: 149-161
        • Meschia J.F.
        • Worrall B.B.
        • Rich S.S.
        Genetic susceptibility to ischemic stroke.
        Nat Rev Neurol. 2011; 7: 369-378
        • Humphries S.E.
        • Morgan L.
        Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches.
        Lancet Neurol. 2004; 3: 227-235
        • Modan M.
        • Halkin H.
        • Karasik A.
        • Lusky A.
        Elevated serum uric acid–a facet of hyperinsulinaemia.
        Diabetologia. 1987; 30: 713-718
        • Lee J.
        • Sparrow D.
        • Vokonas P.S.
        • Landsberg L.
        • Weiss S.T.
        Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study.
        Am J Epidemiol. 1995; 142: 288-294
        • Fang J.
        • Alderman M.H.
        Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey.
        J Am Med Assoc. 2000; 283: 2404-2410
        • Nakanishi N.
        • Tatara K.
        • Nakamura K.
        • Suzuki K.
        Risk factors for the incidence of hyperuricaemia: a 6-year longitudinal study of middle-aged Japanese men.
        Int J Epidemiol. 1999; 28: 888-893
        • Klein R.
        • Klein B.E.
        • Cornoni J.C.
        • Maready J.
        • Cassel J.C.
        • Tyroler H.A.
        Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia.
        Arch Intern Med. 1973; 132: 401-410
        • Bengtsson C.
        • Lapidus L.
        • Stendahl C.
        • Waldenstrom J.
        Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden.
        Acta Med Scand. 1988; 224: 549-555
        • Suarna C.
        • Dean R.T.
        • May J.
        • Stocker R.
        Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate.
        Arterioscler Thromb Vasc Biol. 1995; 15: 1616-1624
        • Nieto F.J.
        • Iribarren C.
        • Gross M.D.
        • Comstock G.W.
        • Cutler R.G.
        Uric acid and serum antioxidant capacity: a reaction to atherosclerosis.
        Atherosclerosis. 2000; 148: 131-139
        • Steinberg H.O.
        • Brechtel G.
        • Johnson A.
        • Fineberg N.
        • Baron A.D.
        Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.
        J Clin Invest. 1994; 94: 1172-1179
        • Baynes J.W.
        Role of oxidative stress in development of complications in diabetes.
        Diabetes. 1991; 40: 405-412

      Linked Article